Objective.—Neurofibromatosis 1 and neurofibromatosis 2 are autosomal dominant genetic
disorders in which affected individuals develop both benign and malignant tumors at an …

Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that
results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It …

The thoroughly updated Fourth Edition of this acclaimed reference describes and illustrates
the full range of pediatric disorders diagnosable by modern neuroimaging. This edition …

Abstract Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the
development of multiple schwannomas and meningiomas. Prevalence (initially estimated at …

Schwannomas may occur spontaneously, or in the context of a familial tumor syndrome such
as neurofibromatosis type 2 (NF 2), schwannomatosis and C arney's complex …

Schwannomas are tumors of the peripheral nervous system, consisting of different cell types.
These include tumorigenic Schwann cells, axons, macrophages, T cells, fibroblasts, blood …

Objective: To estimate the incidence of meningiomatosis and schwannomatosis, and their
familial occurrences and relation to type 2 neurofibromatosis (NF2) in a well-defined …

Abstract Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and
schwannomatosis (SWN) are tumor-suppressor syndromes. Each syndrome is an orphan …

Schwannomatosis is characterized by the predisposition to develop multiple schwannomas
and, less commonly, meningiomas. Despite the clinical overlap with neurofibromatosis type …

A consensus conference on neurofibromatosis 2 (NF2) was held in 2002 at the request of
the United Kingdom (UK) Neurofibromatosis Association, with particular emphasis on …